Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation.

Corti, P

Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation. [electronic resource] - Acta haematologica 2003 - 43-5 p. digital

Publication Type: Case Reports; Journal Article

0001-5792

10.1159/000067271 doi


Anemia, Hemolytic, Autoimmune--drug therapy
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antigens, CD19--blood
B-Lymphocytes--cytology
Female
Hematopoietic Stem Cell Transplantation--adverse effects
Hemoglobins--metabolism
Humans
Infant
Lymphocyte Depletion--adverse effects
Mucopolysaccharidosis I--complications
Rituximab
T-Lymphocytes
Transplantation Chimera
Transplantation, Homologous--adverse effects
Treatment Outcome